Generation and validation of a novel multitarget small molecule in glioblastoma
Abstract The development of multitarget small molecules (MSMs) has emerged as a powerful strategy for the treatment of multifactorial diseases such as cancer.Glioblastoma is the most prevalent and malignant Tool Kits primary brain tumor in adults, which is characterized by poor prognosis and a high heterogeneity.Current standards of treatment prese